Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Hypogonadism Clinical Trials

A listing of Hypogonadism medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (37) clinical trials

A Phase 3, Randomized, Active-controlled, Open-label Study of the Safety and Efficacy of Oral Testosterone Undecanoate (TU) in Hypogonadal Men

Phase

Attention men age 18 to 60: Are you overweight and experiencing symptoms such as low energy, reduced sex drive or mood problems? If so, you may have low testosterone levels We're currently seeking men with low testosterone for a research study of an investigational oral medication. Participation is at no ...

Phase N/A

Testosterone replacement therapy in adult, 18 years or older, males for conditions associated with a deficiency or absence of endogenous testosterone – primary hypogonadism (congenital or acquired) or secondary hypogonadism (congenital or acquired).

Phase

The primary purpose of this study is to compare the effect of testosterone replacement therapy (TRT) and matching placebo (a gel that is made to look like the TRT but does not have any testosterone drug in it) on major Cardiovascular (CV) events such as heart attack and stroke in ...

Phase

ATTENTION MEN Do you have Low Testosterone and are between the ages of 45-80? If so, you may qualify for this study of topical testosterone replacement therapy in men with low testosterone who are at increased risk for Cardiovascular disease.  

Phase

Ambulatory Blood Pressure Monitoring in Oral Testosterone Undeconate (TU, LPCN 1021) Treated Hypogonadal Men

Phase

A study for men with hypogonadal that are increased risk for cardiovascular disease with the use of topical testosterone replacement therapy.  

Phase

Testosterone Therapy in Hypogonadal Men Treated With Opioids

The study duration is 24 weeks. Patients are treated with Testosterone Undecanoate 1000 mg/4 ml, intramuscular (i.m.) or placebo at 0, 6 and 18 weeks. Outcome measures will be evaluated at 0 and 14 weeks.

Phase

Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus

Clinical and Epidemiological Characteristics and Efficacy of Androgen Substitution for Hypogonadism in Men With Type 2 Diabetes Mellitus Under Routine Clinical Practice (DESTINY)

Phase N/A

Extragonadal Effects of hCG on Calcium Homeostasis

Aim To investigate whether human chorionic gonadotropin (hCG) stimulation test changes calcium-phosphate homeostasis in men with normal and impaired testicular function. The overall purpose of the project is to investigate the importance of human chorion gonadotropin (hCG) for the calcium balance in normal men and men with impaired testicular function. ...

Phase N/A